Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To administer recombinant erythropoietin to patients with rheumatoid arthritis who had significant anemia, while monitoring hematologic and rheumatologic clinical responses as well as potential toxicity.Patients and methods Seventeen patients with rheumatoid arthritis from five rheumatology care settings were studied. The patients had initial hematocrits of 34% or less and stable clinical status, and were not being treated with second-line drugs or corticosteroids. An 8-week randomized double-blind study involving various dosages of recombinant erythropoietin, as well as placebo, was followed by a 24-week open-label study in which dosage could be titrated to achieve a normal hematocrit.Results In the 8-week randomized study, four of 13 patients who received injections of recombinant erythropoietin showed a hematologic response, arbitrarily defined as at least a 6-unit increase in hematocrit. None of four placebo-treated patients showed a meaningful hematologic response. All 11 patients who completed the subsequent 24-week open-label study reached a normal hematocrit level at some time during the study, and 10 of 11 showed an increase of hematocrit 6 units or greater. At least one adjustment, i.e., an increase, decrease, or omission of the erythropoietin dosage, was required in all patients to maintain the hematocrit at a target range of 35% for women or 40% for men. Meaningful changes were not seen in patients' capacity to perform activities of daily living or pain levels during either the 8-week randomized study or the 24-week open-label study. No adverse effects were associated with recombinant erythropoietin therapy.Conclusion Patients with rheumatoid arthritis showed excellent hematologic responses to recombinant erythropoietin, without toxicity, during careful monitoring for appropriate dosage adjustment, although a meaningful change in rheumatologic clinical status was not seen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specific studies have been conducted in patients with AI in the setting of rheumatoid arthritis or HIV infection, in which EPO levels <500 U/L predicted a response to ESA administration [144, 145].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [144]
Citations
Cites
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
1958 Revision of diagnostic criteria for rheumatoid arthritis
Ropes, M. W., Bennett, G. A., Cobb, S., Jacox, R., & Jessar, R. A. (1959) · Arthritis & Rheumatism · doi:10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9 · Cited by 1,999
Winearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
Pincus, T., Summey, J. A., Soraci, S. A., Wallston, K. A., & Hummon, N. P. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261107 · Cited by 1,337
Self-citationEschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
Self-citationIncreased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin Therapy
Goodnough, L. T., Rudnick, S., Price, T. H., Ballas, S. K., Collins, M. L., Crowley, J. P., Kosmin, M., Kruskall, M. S., Lenes, B. A., Menitove, J. E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910263211705 · Cited by 484
Nicolle, L. S. (1984) · The Nurse Practitioner · doi:10.1097/00006205-198411000-00004 · Cited by 416
Active and latent forms of transforming growth factor beta activity in synovial effusions.
Fava, R., Olsen, N., Keski-Oja, J., Moses, H., & Pincus, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.291 · Cited by 261
Self-citationAn Additional Basic Science for Clinical Medicine: II. The Limitations of Randomized Trials
FEINSTEIN, A. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-4-544 · Cited by 253
Research works printed but not linked: 1
- Lafyatis, 1988, Demonstration of local production of PDGF and TGF/β by synovial tissue from patients with rheumatoid arthritis, Arthritis Rheum, 31, S62
Cited by
Erythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
Means, R. J., & Krantz, S. (1992) · Blood · doi:10.1182/blood.v80.7.1639.1639 · Cited by 681
Self-citationEffect of inflammatory cytokines on hypoxia-induced erythropoietin production
Faquin, W., Schneider, T., & Goldberg, M. (1992) · Blood · doi:10.1182/blood.v79.8.1987.1987 · Cited by 532
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
SAWKA, M. N., CONVERTINO, V. A., EICHNER, E. R., SCHNIEDER, S. M., & YOUNG, A. J. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200002000-00012 · Cited by 447
Metadata
- Authors
- Pincus, T., Olsen, N. J., Russell, I. J., Wolfe, F., Robert Harris, E., Schnitzer, T. J., Boccagno, J. A., & Krantz, S. B.
- Affiliations
- Vanderbilt University (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Kansas (US)
- Rush University Medical Center (US)
- Corresponding author
- Pincus, Theodore
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1990-08
- Volume
- 89
- Issue
- 2
- Pages
- 161-168
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1969576864
- Cited by
- 226
- References
- 32
- Citations by year
- 2026: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 4 · 2012: 1
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (T 32-07186)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-1555)
- National Center for Research Resources (RR-95)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- recombinant human erythropoietin, rheumatoid arthritis, anemia, hematocrit, dose titration, hematologic response, adverse effects, activities of daily living, pain
- MeSH terms
- Activities of Daily Living, Adult, Aged, Anemia, Arthritis, Rheumatoid, Double-Blind Method, Erythropoietin, Female, Ferritins, Hematocrit, Humans, Male, Middle Aged, Monitoring, Physiologic, Recombinant Proteins, Multicenter Studies as Topic, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. https://app.cochat.ai/papers/10.1016/0002-9343(90)90294-n
- The paper
- Pincus, T., Olsen, N. J., Russell, I. J., Wolfe, F., Robert Harris, E., Schnitzer, T. J., Boccagno, J. A., & Krantz, S. B. (1990). Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(90)90294-n
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.